These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24372252)

  • 1. First steps towards a vaccine against Acinetobacter baumannii.
    Garcia-Quintanilla M; Pulido MR; McConnell MJ
    Curr Pharm Biotechnol; 2013; 14(10):897-902. PubMed ID: 24372252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances and challenges in the development of Acinetobacter vaccines.
    Chen W
    Hum Vaccin Immunother; 2015; 11(10):2495-500. PubMed ID: 26158773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
    McConnell MJ; Rumbo C; Bou G; Pachón J
    Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Antigens Expressing Surface Loops of ZnuD From
    Qamsari MM; Rasooli I; Chaudhuri S; Astaneh SDA; Schryvers AB
    Front Immunol; 2020; 11():158. PubMed ID: 32117294
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.
    Moriel DG; Beatson SA; Wurpel DJ; Lipman J; Nimmo GR; Paterson DL; Schembri MA
    PLoS One; 2013; 8(10):e77631. PubMed ID: 24116234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
    Ni Z; Chen Y; Ong E; He Y
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.
    McConnell MJ; Pachón J
    Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.
    McConnell MJ; Domínguez-Herrera J; Smani Y; López-Rojas R; Docobo-Pérez F; Pachón J
    Infect Immun; 2011 Jan; 79(1):518-26. PubMed ID: 20974823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
    Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
    Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.
    Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J
    Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 18. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
    Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Balthasar JP; Russo TA
    Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947651
    [No Abstract]   [Full Text] [Related]  

  • 19. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
    Ahmad S; Azam SS
    J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.